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Summary
Haematuria may herald the presence of sinister underlying disease, notably malignancy of the urinary tract.
Applying the conventional management pathway involving numerous clinic visits and referrals, waiting list for imaging
studies of the upper tract, diagnostic cystoscopy and then therapeutic endoscopy in different venues often leads to
substantial delay in diagnosis and appropriate intervention. A rapid access haematuria clinic is therefore advocated.
The day case haematuria diagnostic service combining diagnostic imaging and flexible cystoscopy has proven to be
highly effective. In this connection, transabdominal ultrasonography has been employed increasingly as the primary
imaging modality. (HK Pract 1998;20:615-623)
Introduction
Haematur i a of any degree
should never be ignored and in
adults, it should be regarded as a
symptom of urologic malignancy
until proven otherwise.1 Mariani and
associates, in their evaluation of
1000 consecutive patients, revealed
life threatening lesions in 9.1%.2 The
series included 691 patients with
microscopic haematuria and 309 with
gross haematuria of which l ife
threatening lesions were found in
3.9% and 20.7%, r e s p e c t i v e l y
(P< 0.001). It is obvious that the
chances of identifying significant
pathology is much higher with gross
haematuria.
*
 Address for correspondence : Dr S K H Yip, Department of Urology, Singapore General Hospital, Outram Road, Singapore 169608.
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Differential diagnosis of
haematuria
Haematuria may reflect either
r e n a l o r u r o l o g i c a l d i s e a s e .
H a e m a t u r i a of r ena l o r i g i n is
frequently associated with casts in
the u r i n e and is a lmos t a lways
a s s o c i a t e d w i t h s i g n i f i c a n t
p r o t e i n u r i a . Even s i g n i f i c a n t
haematuria of urologic origin does
not elevate the protein concentration
in the urine into the 100-300 mg/dl
range or the 2+ to 3+ range on
dips t i ck , and p r o t e i n u r i a of t h i s
magni tude almost a lways indicates
glomerular disease (Table 1).3
E r y t h r o c y t e s a r i s i n g f r o m
glomeru la r disease are t y p i c a l l y
dysmorphic and show a wide range
of morphologic a l tera t ions . Red
blood cell (RBC) morpho logy is
more eas i ly de te rmined t h r o u g h
phase contrast microscopy, but with
practice this can be accomplished
with a conven t iona l l i g h t micro-
scope.4
Refined urinalysis
F r a c c h i a a n d a s s o c i a t e s
evaluated whether a comprehensive
and ref ined u r i n a l y s i s u t i l i z i n g
qual i ta t ive, quanti tat ive, chemical
and urine sediment parameters might
aid in identifying those patients who
had a significant urologic cause for
their microhaematuria in contrast to
those patients who appeared to have
'pure' renal, i.e. medical bleeding.5
The studied patients submitted a first
m o r n i n g u r i n e specimen for the
refined urine diagnostic assay. This
e x a m i n a t i o n , p e r f o r m e d by a
cytopathologist, was both qualitative
(such as RBC morphology, sediment
casts, and u r i n e c h e m i s t r y ) and
q u a n t i t a t i v e (such as cell count /10
high power f ield, protein in mg/dl).
They noted tha t the presence of
dysmorphic ur inary red blood cells
a n d R B C c a s t s w a s s t r o n g l y
sugges t ive of renal pa r enchyma l
bleeding. Overall, 43 of 44 subjects
(98%) wi th dysmorphic RBCs and
RBC casts failed to demonstrate any
signif icant urological lesion.
However, in this series of 100
patients, the refined urinalysis alone
did not identify any of the three renal
tumours . It was suggested that
r e f i n e d u r i n a l y s i s needed to be
combined with selective upper tract
imaging. Taken together, the sole
presence of dysmorphic RBCs and
RBC casts by refined urinalysis and
Origin
Differential diagnosis aided by microscopy
Examples Typical microscopy and urinalysis
RBC* RBC Casts Proteinuria
Glomerular IgA nephropathy, glomerulonephritis Dysmorphic May be present Significant
Non-glomerular surgical Tumours, urolithiasis Isomorphic Absent Minimal
a negative upper tract evaluation
strongly suggests a non-urologic
cause of haematuria.
Dipstick tests and microscopic
haematuria
The s e n s i t i v i t y of u r i n a r y
dipsticks in identifying haematuria,
defined as more than three RBCs per
high power microscopic field of
centrifuged sediments, is over 90%.
On the other hand, in comparison
with microscopy, the specificity of
the d i p s t i c k fo r h a e m a t u r i a i s
somewhat lower, reflecting a higher |
false positive rate with the dipstick.6
The efficacy of haematuria screening
with the dipstick to identify patients
with significant urologic disease is
somewhat controversial . In older
adul t s , one s tudy from the Mayo
c l i n i c cons is t ing of 2000 patients
w i t h a s y m p t o m a t i c h a e m a t u r i a
showed that only 0.5% had a urologic
malignancy and only 1.8% developed
other serious urologic diseases within
3 years after identif ication of the
haematuria.7 However, Messing et al
found that 26% of asymptomatic men
over 50 years old who had a positive
dipstick reading for haematuria in a
h o m e s c r e e n i n g s t u d y w e r e
s u b s e q u e n t l y f o u n d t o h a v e
*RBC= red blood cell
(Continued on page 618)
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s ign i f ican t u ro log ic pa tho logy ,
i n c l u d i n g 5% to 15% who had
u n s u s p e c t e d b l adde r cancer . 8 - 9
F u r t h e r m o r e , r epea t d i p s t i c k
screening 9 months later in men over
50 whose dipstick ur inalysis was
i n i t i a l l y nega t i ve iden t i f i ed an
addit ional 1.8% with significant
urologic pathology, including 0.8%
with superficial bladder cancer.10
Obviously, the age of the study
population, the completeness of the
subsequent urologic evaluation, and
the definition of significant disease
all influence the benefit of d ips t ick
s c r e e n i n g f o r h a e m a t u r i a i n
a s y m p t o m a t i c p a t i e n t s . I t does
appear , h o w e v e r , t h a t d i p s t i c k
screening for haematur ia is most
effective in men over 50 and could be
done a n n u a l l y to detect bladder
cancer in a superficial stage before
invasion occurs.
Asymptomatic microscopic
haematuria: selection for
investigation?
The i m p l i c a t i o n s of a wide-
spread use of ur ine analysis wi th
dipsticks in health screening clinics
and in routine clinical practice have
resulted in an increased urological
referrals from family physicians for
advice about investigating patients
wi th asymptomat ic microscopic
haematuria. Opinion is divided as to
w h o n e e d s r e f e r r a l a n d h o w
extensively they should be evaluated.
Some authorities recommended the
i n v e s t i g a t i o n o f a n y o n e w i t h
microscopic haematuria, irrespective
of age, sex or whether associated
with any symptoms.11-13
On the other hand, Sultana et al
were of the opinion that careful
selection was necessary to be able to
better use the available facilities and
increase the diagnostic yield giving
pr ior i ty to those pat ients with a
greater risk of having an underlying
urologic malignancy.14 They studied
the difficult but important subject of
how microscopic haematuria, and in
particular asymptomatic microscopic
haematuria, should be investigated,
by describing the resul ts obtained
from 381 patients investigated for
microscopic haematuria over a period
of one year. No mal ignancy was
found in any patient under 50 years
of age (n= 131 ) ; whi le in patients
aged over 50 years, the overa l l
incidence of malignancy was 7.5%
(19/250). During the same period,
233 patients were referred with gross
haematuria. In these patients, those
aged under 50 years had a 10%
incidence of m a l i g n a n c y (6/60),
while in those aged over 50 years the
incidence was 34.5% (60/173). They
concluded that the investigation of
older pa t ients with microscopic
haematuria (and all those with gross
haematuria) was well justified, as
mal ignancy wou ld be found in a
signif icant proportion even if they
were asymptomatic. The benefit of
a f u l l urologic i n v e s t i g a t i o n of
younger patients with microscopic
haematuria was debatable.
The authors' preference is that
the in i t i a l diagnostic approach to
asymptomatic microhaematuria of
patients includes renal ultrasound,
x-ray of kidneys, ureter and bladder
(KUB) and f l ex ib le cystoscopy,
acknowledging that a rare, small and
n o n - o b s t r u c t i n g renal pe lv i s or
ureteral tumour might be missed.
Little in sensitivity and specificity
with regards to tumour detection is
sacrificed with this strategy. This
view is shared by other authors.15"16
For patients over 40 years old, more
ex tens ive i n v e s t i g a t i o n may be
warranted. This entails an upper
tract imaging (e.g. ultrasonography)
and lower tract endoscopy, to be
followed by an alternative imaging
(e.g. in t ravenous urography) and
c y t o l o g y i f t he re i s p e r s i s t e n t
microhaematuria. After a negative
urologic work-up, patients under 40
y e a r s o l d w i t h a s y m p t o m a t i c
microhaematuria should be referred
for a n e p h r o l o g i c a l o p i n i o n ,
part icular ly if they have persistent
p r o t e i n u r i a o r h y p e r t e n s i o n . 1 7
Twenty-four hours ur inary protein
level, creatinine clearance and serum
C3/C4 complement levels can be
carried out by the family physician
and w i l l enable more se lec t ive
referral of those w i t h abnormal
results.
Upper tract imaging: which
modality to choose?
I n u p p e r t r a c t i m a g i n g ,
ultrasonography (USG) is safer and
cheaper than intravenous urography
(IVU).15 It is well recognized that a
p r o p o r t i o n of sma l l rena l cell
carcinoma are undetected by IVU,
e v e n w i t h t h e a d d i t i o n o f
t o m o g r a p h y , and t h a t USG is
superior for imaging parenchymal
renal masses.18-20 Conversely, IVU
more readily detects upper tract
transitional cell carcinoma (TCC),
which is poorly detected by USG
unless it is associated with upper
t r a c t d i l a t a t i o n . O v e r a l l ,
p a r e n c h y m a l r e n a l t u m o u r s
represents 80 to 90% of primary
upper tract malignancies in adults.
(Table 2)
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Comparing ultrasonography and
Cost
Preparation
Availability
Prior to imaging
Additional information
Irradiation
Allergy
Superior for detecting
Inferior for detecting
Ultrasonography
cheap
minimal, full bladder essential
can be performed in clinic, or
in ward using portable machines
good quality KUB
color Doppler
nil
nil
- renal parenchymal lesion
- bladder tumour and stone
- differentiating cystic/solid lesion
- ureteric stone without obstruction
- small upper tract TCC*
Urography
slightly more expensive
light bowel preparation required
radiology suite
serum creatinine
tomography
yes
small risk
- calculi and upper tract urothelial tumour
- qualitative renal function assessment
- road-mapping endourological procedures
- small (< 2.5 cm) renal lesion
- bladder lesion
* TCC = Transitional cell carcinoma
We compared the efficacy of
USG and IVU by conduc t ing a
prospective study on 146 consecutive
patients presenting wi th painless
gross haematuria.2 1 Forty seven
genitourinary malignancies (32%)
were detected, of which 72% were
carc inoma of the b l adde r . The
sensi t ivi ty and specificity of USG
and IVU were comparable for the
, upper tract; but in the lower tract
e v a l u a t i o n , s e n s i t i v i t y w a s
significantly higher for USG (96%)
compared with IVU (50%) (p < 0.05);
while the specificities were similar.
The se r ies was updated to
include 468 patients from 1992 to
1997 wi th very s imi l a r f i n d i n g s
regarding incidence of pathologies
and accuracy of imaging modalities
(unpublished data). We concluded
that USG is more sensitive than IVU
for diagnosing urologic malignancies
in patients presenting with painless
haematuria, where carcinoma of the
bladder is the commonest pathology.
Its utilization as the initial screening
i n v e s t i g a t i o n i s r ecommended .
Patients diagnosed to be suffering
from carcinoma of bladder by
ultrasound should be scheduled
promptly for therapeutic endoscopy.
R a p i d access c l in ic : to
minimize delay
P a t i e n t s t e n d t o r e p o r t
haematuria to their family physicians
fairly quickly. Stower reported that
the median delay was one week.22
The meri ts of a rapid haematur ia
d i a g n o s t i c service in a te r t ia ry
referral centre are therefore two-fold.
It a ims to encourage immedia te
r e f e r r a l , a n d t o o f f e r e a r l y
investigation.23 Definitive treatment
can then be scheduled on a priority
basis once diagnosis is confirmed.
Britton reviewed the effective-
ness of the haematuria clinic and
considered that an 'open access
haematuria c l in ic ' to be the ideal
system where referral is by phone
and all investigations, including urine j
m i c r o s c o p y , u r i n e c y t o l o g y , |
intravenous urography and flexible
cystoscopy, are performed at one
visi t (Table 3). This system wil l
require considerable effort of co-
operation with the family physician,
the patients and most importantly
one ' s r a d i o l o g i c a l co l l eagues ;
arrangement with the latter may be
the l imi t ing factor. Lynch reported
his experience of such an open access
cl inic in the investigation of 395
patients and commented that it was
efficient and easily run.24
In fact, as early as in 1990, Plail
predicted that integrated, single visit
haematur ia clinics might soon be
(Continued on page 621)
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common place.25 His prediction was
based on the increasing accuracy of
ultrasonography and availability of
o u t p a t i e n t f l e x i b l e cys toscopy
examination. However, while there
were a number of reports on the
efficacy of haematuria clinics, IVU
remained to be the primary imaging
modality.26-27
We r e c e n t l y r epo r t ed the
efficacy of a Day Case Diagnostic
Service employing ultrasonography
and f l e x i b l e cys toscopy in the
evaluation of patients presenting with
painless gross haematuria.28 While
we emphasized direct access from the
Accident and Emergency Department
to our Urology clinic appointment
system for urgent referrals, we also
accepted referrals by fax from family
physicians. From July 1994 to June
1997, 312 consecu t ive pa t i en t s
p re sen t i ng with pa in less gross
haematuria were studied. They were
seen in the next clinic slot (by
allowing forced-in quota) for first
consultat ion wi th in one week of
referral. This was followed shortly
by e v a l u a t i o n in a Day Case
Diagnostic Service setting, where
u l t r a s o n o g r a p h y a n d f l e x i b l e
cystoscopy were performed together
with other laboratory investigations.
I n t r a v e n o u s u r o g r a p h y w a s
performed subsequently for possible
additional diagnostic information.
Eighty-one urinary malignancies
were detected in 78 patients, 51
being carcinoma of bladder, followed
by renal cell carcinoma (n = 15). A
definitive diagnosis was made in 68
cases and an abnormality was noted
in nine other cases after the day case
work up. Decision of fur ther
management and listing for surgery,
where appropriate, was made in the
Day Case Diagnostic Clinic. The day
case diagnostic work-up has also led
to h i g h l y se l ec t ive c o m p u t e d
t o m o g r a p h y (CT) w i t h h i g h
diagnostic yield; whereas intravenous
urography only added important
diagnostic information, not available
in the ear l ie r w o r k - u p in n ine
patients.28
Table 3: Where is the delay?*
1. Onset of haematuria and consultation
2. Initial consultation with GP and hospital referral
3. Hospital referral and attendance at clinic
4. Attendance at clinic and investigations
5. Investigations and then review in clinic
6, Waiting list time for diagnostic cystoscopy
7. Waiting list time for definitive treatment
We conclude that the Day Case
Diagnostic Service is a feasible
a r r a n g e m e n t . B y c o m b i n i n g
u l t r a s o n o g r a p h y a n d f l e x i b l e
c y s t o s c o p y , t he m a j o r i t y o f
pathologies were diagnosed and
abnormal i t i e s detected. Such a
service enhances rapid completion of
t h e d i a g n o s t i c w o r k - u p , a n d
operations for surgical conditions can
be scheduled promptly. (Figure 1)
Patient delay
GP delay
Hospital delay
Hospital delay
Hospital delay
Hospital delay
Hospital delay
* Adapted from Britton JP. Review: Effectiveness of Haematuria Clinics (Br J Urol I993;7l;
247-452) •• .
Figure 1: Optimal management pathway for haematuria
Patients presenting with painless gross haematuria
Direct access clinic
Day case imaging & cystoscopy
(Ultrasonography preferred)
Pathology identified
Early surgery
Inconclusive
Alternative imaging,
urine cytology and others
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1. Haematuria is a worrying symptom which may suggest an underlying urologic malignancy.
2. The family physician can assist in the management by careful evaluation of the patient and initiating appropriate
investigations, including proper urinalysis and imaging studies.
3. Ultrasonography together with plain KUB film is the preferred primary imaging modality.
4. If there is reasonable suspicion of an underlying pathology, the family physician should alert the specialist
and ensure that there is minimal delay for formal urologic work-up.
5. Referral centres should make every effort to minimize the hospital delay.
Whether the rapid diagnostic service
can be conver ted to s u b s t a n t i a l
improvement in su rv iva l outcome
cannot be assessed in the current
study,29 but the relief of patients '
anxiety is beyond doubt. The impact
on clinical service improvement is
a lso t r e m e n d o u s , s ince we have
s h o w n t h a t c lose c o - o p e r a t i o n
between different specialties leads to
achievement of a high qual i ty of
service.
The family physician may opt to
a r r a n g e f o r i m a g i n g s t u d i e s
(u l t r a sonography or IVU where
indicated) while the patient awaits
for specialist opinion. Such pre-
consultat ion imaging has also been
reported to m i n i m i z e the delay in
diagnosis and would be appreciated
especially in busy tertiary referral
centres.30
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